test

Patient & Cancer Information | Our Experts | Expert Profiles

Alfred Ian Lee MD, PhD

Assistant Professor of Medicine (Hematology); Associate Firm Chief, Smilow-11, Yale Cancer Center; Assistant Program Director, Traditional Internal Medicine Residency Program

Clinical Interests

Lymphoma; platelet disorders; thrombosis; bleeding; coagulation disorders; leukemia

Board Certifications

2007
Internal Medicine, Board Certified
Hematology/Oncology, Board Eligible

Patient Care Locations

alfred_leefaculty-clinicsfalsetruetrue6truefalsefalse

Clinical Trials

ConditionsStudy Title
Myelodysplastic SyndromesPhase III, Multi-Center, Randomized, Controlled Study to Assess the Efficacy and Safety of ON 01910.Na Administered in a 72-Hour Continuous IV Every Other Week in Myelodysplastic Syndrome Patients with Excess Blasts Relapsing After, or Refractory to, or Intolerant to Azacitidine or Decitabine.

Edit Profile